Zurich: Swiss Mr.
SwissMedic Regulator said on Monday it was approved by Ronapreve, antibody treatments developed jointly by Roche and Regeneron, to treat Covid-19 patients.
“In this procedure, there is no data on the efficacy of the omicron variant submitted,” SwissMedic said in a statement.
Antibodies have been authorized for recipes in Switzerland under Covid-19 Ordinance 3 since April 15, SwissMedic said.
SwissMedic approved Ronapreve Roche to treat patients covid-19
